Scinai Immunotherapeutics Ltd. (TLV:BVXV)

Scinai Immunotherapeutics Revenue

Scinai Immunotherapeutics had revenue of $460.00K USD in the quarter ending June 30, 2026, with 145.99% growth. This brings the company's total for the last twelve months to $1.49M, up 29.64% year-over-year. In the year 2025, Scinai Immunotherapeutics had annual revenue of $1.31M with 99.24% growth.

• Revenue (ttm): $1.49M
• Revenue Growth: +29.64%
• P/S Ratio: 0.52
• Revenue / Employee: $33.04K
• Employees: 45
• Market Cap: 2.32M ILS

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.31M	653.00K	99.24%
Dec 31, 2024	658.00K	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 26, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 2, 2026

Data Sources Report a data error